Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients ; volume:38 ; number:3 ; day:7 ; month:12 ; year:2023 ; pages:640-647 ; date:3.2024
Leukemia ; 38, Heft 3 (7.12.2023), 640-647, 3.2024

Creator: Mai, Elias K.
Hielscher, Thomas
Bertsch, Uta
Salwender, Hans
Zweegman, Sonja
Raab, Marc-Steffen
Munder, Markus
Pantani, Lucia
Mancuso, Katia
Brossart, Peter
Beksaç, Meral
Blau, Igor-Wolfgang
Dürig, Jan
Besemer, Britta
Fenk, Roland
Reimer, Peter
Holt, Bronno van der
Hänel, Mathias
Metzler, Ivana von
Graeven, Ullrich
Müller-Tidow, Carsten
Boccadoro, Mario
Scheid, Christoph
Dimopoulos, Meletios A.
Hillengaß, Jens
Weisel, Katja
Cavo, Michele
Sonneveld, Pieter
Goldschmidt, Hartmut

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41375-023-02105-6

URN: urn:nbn:de:101:1-2405080936000.695379180469

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 8:52 AM UTC

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Other Objects (12)

Hochschulschrift

The landscape of small nucleolar RNA expression and potential roles of RNA modifications in multiple myeloma

Hochschulschrift

Targeting hematopoietic niche-related mechanisms to overcome therapy resistance in acute myeloid leukemia

Hochschulschrift

Identification of RPS6KA1 as a mediator of resistance to Venetoclax/Azacytidine-combination treatment in Acute Myeloid Leukemia by genome-scale CRISPR/Cas9 knockout screening

Hochschulschrift

Expressionsanalyse und funktionelle Charakterisierung von Zyklin A1 und der Interaktionspartner des Zyklin A1-CDK2-Komplexes

Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma

S282: A randomized controlled clinical trial demonstrates that plasma from convalescent and vaccinated donors improves outcome of COVID-19 in patients with hematological disease, cancer or immunosuppression

Myeloische Neoplasien

Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma Patients

Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD

AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting

Workflow to improve patient recruitment for clinical trials within hospital information systems – a case-study

Hochschulschrift

Leukemia stem cell fates are determined by DNA methylation levels

Hochschulschrift

The landscape of small nucleolar RNA expression and potential roles of RNA modifications in multiple myeloma

Hochschulschrift

Targeting hematopoietic niche-related mechanisms to overcome therapy resistance in acute myeloid leukemia

Hochschulschrift

Identification of RPS6KA1 as a mediator of resistance to Venetoclax/Azacytidine-combination treatment in Acute Myeloid Leukemia by genome-scale CRISPR/Cas9 knockout screening

Hochschulschrift

Expressionsanalyse und funktionelle Charakterisierung von Zyklin A1 und der Interaktionspartner des Zyklin A1-CDK2-Komplexes

Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma

S282: A randomized controlled clinical trial demonstrates that plasma from convalescent and vaccinated donors improves outcome of COVID-19 in patients with hematological disease, cancer or immunosuppression

Myeloische Neoplasien

Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma Patients

Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD

AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting

Workflow to improve patient recruitment for clinical trials within hospital information systems – a case-study

Hochschulschrift

Leukemia stem cell fates are determined by DNA methylation levels

Hochschulschrift

The landscape of small nucleolar RNA expression and potential roles of RNA modifications in multiple myeloma

Hochschulschrift

Targeting hematopoietic niche-related mechanisms to overcome therapy resistance in acute myeloid leukemia

Hochschulschrift

Identification of RPS6KA1 as a mediator of resistance to Venetoclax/Azacytidine-combination treatment in Acute Myeloid Leukemia by genome-scale CRISPR/Cas9 knockout screening

Hochschulschrift

Expressionsanalyse und funktionelle Charakterisierung von Zyklin A1 und der Interaktionspartner des Zyklin A1-CDK2-Komplexes

Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma

S282: A randomized controlled clinical trial demonstrates that plasma from convalescent and vaccinated donors improves outcome of COVID-19 in patients with hematological disease, cancer or immunosuppression

Myeloische Neoplasien

Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma Patients

Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD

AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting

Workflow to improve patient recruitment for clinical trials within hospital information systems – a case-study

Hochschulschrift

Leukemia stem cell fates are determined by DNA methylation levels

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read and agree to the privacy policy for the collection of personal data.*

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients

Show object

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

The landscape of small nucleolar RNA expression and potential roles of RNA modifications in multiple myeloma

Targeting hematopoietic niche-related mechanisms to overcome therapy resistance in acute myeloid leukemia

Identification of RPS6KA1 as a mediator of resistance to Venetoclax/Azacytidine-combination treatment in Acute Myeloid Leukemia by genome-scale CRISPR/Cas9 knockout screening

Expressionsanalyse und funktionelle Charakterisierung von Zyklin A1 und der Interaktionspartner des Zyklin A1-CDK2-Komplexes

Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma

S282: A randomized controlled clinical trial demonstrates that plasma from convalescent and vaccinated donors improves outcome of COVID-19 in patients with hematological disease, cancer or immunosuppression

Myeloische Neoplasien

Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma Patients

Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD

AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting

Workflow to improve patient recruitment for clinical trials within hospital information systems – a case-study

Leukemia stem cell fates are determined by DNA methylation levels

The landscape of small nucleolar RNA expression and potential roles of RNA modifications in multiple myeloma

Targeting hematopoietic niche-related mechanisms to overcome therapy resistance in acute myeloid leukemia

Identification of RPS6KA1 as a mediator of resistance to Venetoclax/Azacytidine-combination treatment in Acute Myeloid Leukemia by genome-scale CRISPR/Cas9 knockout screening

Expressionsanalyse und funktionelle Charakterisierung von Zyklin A1 und der Interaktionspartner des Zyklin A1-CDK2-Komplexes

Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma

S282: A randomized controlled clinical trial demonstrates that plasma from convalescent and vaccinated donors improves outcome of COVID-19 in patients with hematological disease, cancer or immunosuppression

Myeloische Neoplasien

Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma Patients

Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD

AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting

Workflow to improve patient recruitment for clinical trials within hospital information systems – a case-study

Leukemia stem cell fates are determined by DNA methylation levels

The landscape of small nucleolar RNA expression and potential roles of RNA modifications in multiple myeloma

Targeting hematopoietic niche-related mechanisms to overcome therapy resistance in acute myeloid leukemia

Identification of RPS6KA1 as a mediator of resistance to Venetoclax/Azacytidine-combination treatment in Acute Myeloid Leukemia by genome-scale CRISPR/Cas9 knockout screening

Expressionsanalyse und funktionelle Charakterisierung von Zyklin A1 und der Interaktionspartner des Zyklin A1-CDK2-Komplexes

Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma

S282: A randomized controlled clinical trial demonstrates that plasma from convalescent and vaccinated donors improves outcome of COVID-19 in patients with hematological disease, cancer or immunosuppression

Myeloische Neoplasien

Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma Patients

Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD

AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting

Workflow to improve patient recruitment for clinical trials within hospital information systems – a case-study

Leukemia stem cell fates are determined by DNA methylation levels

Related objects

Reset password